{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Oklahoma City",
      "state": "OK",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "92081",
      "recalling_firm": "PD-Rx Pharmaceuticals, Inc.",
      "address_1": "727 N Ann Arbor Ave",
      "address_2": "",
      "postal_code": "73127-5822",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the US.",
      "recall_number": "D-0559-2023",
      "product_description": "Glimepiride USP, 4 mg, 90 count-bottles, Rx only, Intas Pharm. Limited Pkg By: PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127, NDC 43063-0587-90",
      "product_quantity": "186 bottles",
      "reason_for_recall": "CGMP deviations.",
      "recall_initiation_date": "20230406",
      "center_classification_date": "20230501",
      "termination_date": "20240430",
      "report_date": "20230510",
      "code_info": "Lots: A22B45 Exp. 01/31/24; C22A73, E22E41, C22D28, F22B68, G22A29, H22B97, K22A36 Exp. 03/31/24; K22B99, A23D07, B23B25 Exp. 10/31/24; B23B55 Exp. 06/30/25",
      "more_code_info": ""
    }
  ]
}